Nippon Fine Chemical

Takasago, Hyogo, Japan
Hybrid — also manufactures internal programs
mRNA/LNP Lipids Small Molecule API
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (1) ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP ✓ HC GMP (3)

Quick Facts: Nippon Fine Chemical

Signal Score
Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
Headquarters
Takasago, Hyogo, Japan
Website
Modalities
mRNA/LNP, Lipids, Small Molecule API
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring

About Nippon Fine Chemical

Nippon Fine Chemical makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: mRNA/LNP, Lipids, Small Molecule API. 1 manufacturing site registered with the U.S. FDA and Health Canada. Website: https://www.nipponseika.co.jp/en/

Signal Score

Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works

Nippon Fine Chemical FDA Inspection History

2025-11
NAI VAI OAI
Date Site Type Observations Classification
2025-11-14
Nippon Fine Chemical Co., Ltd.
Takasago Company-level
Drug Quality Assurance No Voluntary Action Indicated (VAI)
Source: FDA Data Dashboard · Retrieved Oct 31, 2026

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source: public careers pages · Checked Oct 30, 2026

Frequently Asked Questions About Nippon Fine Chemical

How many FDA inspections does Nippon Fine Chemical have on record?
CDMO Signal tracks 1 FDA inspection for Nippon Fine Chemical, sourced from the FDA inspection database. See the full inspection history above.
Has Nippon Fine Chemical received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Nippon Fine Chemical.
Does Nippon Fine Chemical have a CDMO Signal Score?
Not yet. Nippon Fine Chemical is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Nippon Fine Chemical for a manufacturing program?
Use the free AI matchmaker to compare Nippon Fine Chemical against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
mRNA/LNP CDMOs →

Similar CDMOs

Avanti Polar Lipids
Alabaster, Alabama, United States
Lipids, mRNA/LNP, Small Molecule API
Asahi Kasei Finechem
Nobeoka, Miyazaki, Japan
Small Molecule API, High-Potency APIs, Custom Synthesis, Lipids
EUROAPI
France
Small Molecule API, Oligonucleotide, Peptides, Lipids, Microbial Fermentation, Particle Engineering
Raffles PharmaTech
Huizhou, Guangdong, China
Small Molecule API, Intermediates, Lipids, Oligonucleotide, Custom Synthesis
Huateng Pharma
Changsha, Hunan, China
ADC / Bioconjugation, Lipids, Intermediates, Small Molecule API, Custom Synthesis

Compare Nippon Fine Chemical with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Nippon Fine Chemical
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.